ClinicalTrials.gg

Program

metaxalone

Also written as “Metaxalone Pill”, “Metaxalone 640 mg” and “Metaxalone 800 MG”.

Its studies are mostly in Spinal Stenosis, led by Primus Pharmaceuticals.

Furthest: phase 4, since Nov 27, 20234 company-led studies, 3 open or runningNext primary completion: Jan 15, 2027 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Primus Pharmaceuticals43 open or runningphase 4since Nov 27, 2023Nov 27, 2023Jan 15, 2027phase 4 · NCT07801066

Also a collaborator on its studies: clinohio-research-services-llc.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 27, 2023First study: phase 4 study in Spinal StenosisFirst studyNCT06157177 · 50 planned · United States
  2. Mar 30, 2024Phase 4 study in Healthy ParticipantsNCT06348303 · 20 enrolled · United States
  3. Aug 28, 2026Phase 4 study in Healthy ParticipantsNCT07801066 · 20 planned · United States
  4. Nov 3, 2026Phase 4 study in Healthy ParticipantNCT07932613 · 20 planned · United States

Ahead

  1. Nov 15, 2026Primary completion: phase 4 study in Spinal StenosisNCT06157177
  2. Jan 15, 2027Primary completion: phase 4 study in Healthy ParticipantsNCT07801066
  3. Jul 15, 2027Primary completion: phase 4 study in Healthy ParticipantNCT07932613

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07932613Healthy Participant · United States4Not yet recruitingJul 15, 202720
NCT07801066Healthy Participants · United States4RecruitingJan 15, 202720
NCT06348303Healthy Participants · United States4CompletedSep 5, 202420
NCT06157177Spinal Stenosis · United States4RecruitingNov 15, 202650

How it is read

Names in the registry

  • “Metaxalone Pill”, 1 entry
  • “Metaxalone 640 mg”, 1 entry
  • “Metaxalone 800 MG”, 1 entry
  • “Metaxalone 640 mg Oral Tablet”, 1 entry
  • “Metaxalone m640 mg oral tablet”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.